{"name":"AIM Therapeutics Inc.","slug":"aim-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQjVVeml4TzVEVzdwTEw5c05xSjVlZ1NuSldhT0MwNnpNWS1nWUlodnBfY1duNFhua1JmNHFnX1RzMER4UXVPTU45OVFOcUt1RkV3bVUzc2NhOUUwYWc3WnlsYzZXNnBIY3V2QkxtVUpDZ2pjdE8wZ0lGUlZZZnZNSVFzcjMzcEJZVUZWUjRTVnBnVU5JcXdycnJlZG9ESW5pWjRicWs0SE81Qzg?oc=5","date":"2026-03-27","type":"deal","source":"Share Talk","summary":"Coiled Therapeutics plc (AIM: COIL) Admission to Trading and First Day of Dealings - Share Talk","headline":"Coiled Therapeutics plc (AIM: COIL) Admission to Trading and First Day of Dealings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOQXhGU1Y0WHZrWDBvWnltSTRicGdrVC11RVJCUjYwR3NQXzJKYmJId280bXZBcE9ha3RiUy0xaXNmRDFBOXlITTVCVVcyRWp0NUZKdGF1Mmc0QjJLTHhRc1hLQVg4bkllenc0Z0RKQkdaT2c4TS13dXpjbHNNUzd3OWwyRHowLTZrNzdLc0NocFRaRlUxM2NjemlYcmNrNWJTUkxVYjhRdEtIcGdnRDJUdVo2YTdtcDJkeTVyXw?oc=5","date":"2026-03-25","type":"pipeline","source":"Sharecast.com","summary":"Crism completes manufacture of first ChemoSeed chemical batch - Sharecast.com","headline":"Crism completes manufacture of first ChemoSeed chemical batch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5INmJER1ZydWpkOFNaMi1PRmgwT3BxRkxXeTRpeFNCeUF1X09GX3lwRTgzb1p2NHlON2Y4Z3JhS1c1QlU5bHFYQXNwZTNyc3I3eVZsSHAtc08yS2J3b3VsQmxaN2toMHVsLVY2Tg?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Aim Immunotech (AIM) - Stock Titan","headline":"If You Invested $1,000 in Aim Immunotech (AIM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPV3NiMjBLRHM3ZFAzNWhpSnZheFQtSlhSeGlwYVQ5TElrSTItTllKbXpjei1ic3hJR2IxVy03TGR6TlZnaGtHS25rSjFzaUdtY3dVRTZYenVVOEE0NlVoTUpTeVE1UXh4SlJHMm94dmt6MllWZHNqQ0dQejNQd01JcC1XbmlmQVIzMTAwZHJMSmpZS081T2IzU3h6RlBYeXh6ZGlsdkxJVk5YQ0NtelFCRk1pQlA3bDQ?oc=5","date":"2026-02-13","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's After-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNRG5hMlZBazhvR1RUUDAtbnBaRjJYNDVTS19Xclo0bjRuRUdjYjBxbUZ4MlFPVWk4QXo5V3poRE9yTDNvRmtKRXJrV3Z6VHVzb3RCSnJJbWJfNnJnck0xRktpR0pLbVFtdHV6N09EMTI5Q0NWb3c3SnRld0ViazNJczZmblZQX3luM3VJZWQ0bmdJVE9QRHl4TmJ1Vzc3TXNoaVpMb2IzbFUwczFuYkdTMGstVWN2bGdz?oc=5","date":"2026-02-06","type":"pipeline","source":"Stock Titan","summary":"Pancreatic cancer focus: AIM ImmunoTech CEO joins Webull live webinar - Stock Titan","headline":"Pancreatic cancer focus: AIM ImmunoTech CEO joins Webull live webinar","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-05","type":"pipeline","source":"GlobeNewswire","summary":"AIM ImmunoTech Reports Positive Year-End Interim Clinical - GlobeNewswire","headline":"AIM ImmunoTech Reports Positive Year-End Interim Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNSUxiVFdFdlNkX3F1SEVkRWVlNkZLaEJkNk1iY0xpeTRPMkRCSFAzVm9ZSlp4cl9RUnpUUElRdko3SF81ZF9mSzhYQVI4U3BaUzFUT21udmg1dWF4czZJUWNLOVRGbTBqMWxJRWJZSUJjdVhSOXFMMF96OV9nMVlyUjJ4Vm5kUEgxODA0VmxpNG1XbE5ScFpQalNiaG9JelBxb0kwM3I0SlM0aVpLcXdQYjNrbjJrbUFuUldQS2xjWEtQRFpjUFFDZTVBRWtIbE04dDluNnVOZWxHbElJNW81b2pJLVFOWWFCQ3hFdVd3?oc=5","date":"2026-01-23","type":"pipeline","source":"GlobeNewswire","summary":"AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering - GlobeNewswire","headline":"AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNWxwYXJ0NWJZdHUxZTRJaU1Va1V0emRVdGxuX3E3cE5DaHdyWTNGeWx5Rl9FZXVHaElSb2dta0tjX1YtbGFNQlJWN0hRSTkzLThTUWVITEpSWk9CTkk2N0xoT3ZmWm9yaktqX1Z5bXdnM2k5U2NEcS01aG5WeGNyNzFCc3N4azlCLWJqOF9n?oc=5","date":"2025-12-30","type":"pipeline","source":"Yahoo Finance","summary":"AIM ImmunoTech Announces Stock Dividend - Yahoo Finance","headline":"AIM ImmunoTech Announces Stock Dividend","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPaG1UUEJXQ2h3TUtHQzBFZ3BGdUhzS2x3c1FPNUxaT3owTjdkdXVBaTdqN2V1dmF0Y1RZQ1JSOGtSSkpYcmY3MGRVazE5WFBPUkJxWkxURTQ2LUNrWGxZbWRRbGRWTzY0YlRwZmpZWEQydWNmVUdGcEo2R1VDaHlwZnhPTGRYRlQxdGpLdUF3Yw?oc=5","date":"2025-12-01","type":"pipeline","source":"Yahoo Finance","summary":"AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series - Yahoo Finance","headline":"AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQTnNUUlZNYjUyWkRzbGtKUkdOeVRFSlcwZC1uQlllUXNQRl9rLWl4cVBLWlJoS3R2TUhtNllHNEs3SzZFNzRZZk0xWk1IV01DeENMQ3NZdnJZandBRXZpakdiMW5tcS1GVjNMbXEwMHllVG9uV2Uxa3drcXg1VHpuOUJuR3VBUE05QUJkdXM3R0x3Q1JvQUpFMVJvTEhsbXNfUF9F?oc=5","date":"2025-09-08","type":"pipeline","source":"BioPharma Dive","summary":"A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria - BioPharma Dive","headline":"A UK biotech takes aim at Parkinson’s, ALS by drugging mitochondria","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxObUVpMXNoSnhyai1SbHd2aDBTSjJMdWJGaW1zSm5RUGxiZ01IUmpQcGFaa0dEZE5GX01HaGhYdEY2dW8wZVFaZDZkNERKS21fUE9uZjNuVmVDZ1VjZkVfRVVLR2JBNVNKWU1FMGcxUE5icWFkOGNpamE5bDExWGhqYVBOWTV5TlFibUJDRGpLQ1BjbVVVRG1McmZNOUswZjZxYUYtSTVHOUl6TUtVU2pkeW9CU3djWGQwZUsyVWE2OU1GQ0pmNEJIMG5xcXp3NEUwN2ZkWFpRenpkUQ?oc=5","date":"2025-07-08","type":"pipeline","source":"Proactive Investors","summary":"Celadon Pharmaceuticals CEO outlines strategic plans targeting growth - Proactive Investors","headline":"Celadon Pharmaceuticals CEO outlines strategic plans targeting growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-07-03","type":"deal","source":"ET Pharma","summary":"Alembic Pharmaceuticals Acquires Utility Therapeutics to Enter U.S. Branded Drug Market - ET Pharma","headline":"Alembic Pharmaceuticals Acquires Utility Therapeutics to Enter U.S. Branded Drug Market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}